Sebastien CAILLE

Person

Moorpark, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Synthesis of omecamtiv mecarbil
- Patent number 12,269,811
- Issue date Apr 8, 2025
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts and crystal forms of omecamtiv mecarbil
- Patent number 11,926,592
- Issue date Mar 12, 2024
- Amgen Inc.
- Henry Morrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of omecamtiv mecarbil
- Patent number 11,753,394
- Issue date Sep 12, 2023
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for preparing a MDM2 inhibitor
- Patent number 11,753,386
- Issue date Sep 12, 2023
- Amgen, Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of omecamtiv mecarbil
- Patent number 11,702,380
- Issue date Jul 18, 2023
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts and crystal forms of omecamtiv mecarbil
- Patent number 11,465,969
- Issue date Oct 11, 2022
- Cytokinetics, Inc.
- Henry Morrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of omecamtiv mecarbil
- Patent number 11,040,956
- Issue date Jun 22, 2021
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,855,259
- Issue date Jan 2, 2018
- Amgen Inc.
- Matthew Bio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,801,867
- Issue date Oct 31, 2017
- Amgen Inc.
- Matthew Bio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Calcium propane-2-sulfinate dihydrate
- Patent number 9,757,367
- Issue date Sep 12, 2017
- Amgen Inc.
- Sebastien Caille
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,623,018
- Issue date Apr 18, 2017
- Amgen Inc.
- Matthew Bio
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes of making and crystalline forms of a MDM2 inhibitor
- Patent number 9,376,386
- Issue date Jun 28, 2016
- Amgen, Inc.
- Matthew Bio
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SYNTHESIS OF A KIF18A INHIBITOR
- Publication number 20250129050
- Publication date Apr 24, 2025
- Amgen Inc.
- Sebastien CAILLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL
- Publication number 20240199550
- Publication date Jun 20, 2024
- Amgen Inc.
- Henry Morrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes for Preparing a MDM2 Inhibitor
- Publication number 20230379796
- Publication date Nov 23, 2023
- Amgen, Inc.
- Sebastien Caille
- H04 - ELECTRIC COMMUNICATION TECHNIQUE
Information Patent Application
SYNTHESIS OF OMECAMTIV MECARBIL
- Publication number 20230373955
- Publication date Nov 23, 2023
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20230301974
- Publication date Sep 28, 2023
- Amgen Inc.
- Matthew BIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND
- Publication number 20230192682
- Publication date Jun 22, 2023
- Amgen Inc.
- Michael Thomas CORBETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL
- Publication number 20230108971
- Publication date Apr 6, 2023
- Amgen Inc.
- Henry Morrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF OMECAMTIV MECARBIL
- Publication number 20220298099
- Publication date Sep 22, 2022
- Amgen Inc.
- Sebastien CAILLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20220280496
- Publication date Sep 8, 2022
- Amgen Inc.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF OMECAMTIV MECARBIL
- Publication number 20210371397
- Publication date Dec 2, 2021
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes for Preparing a MDM2 Inhibitor
- Publication number 20210347743
- Publication date Nov 11, 2021
- Amgen, Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL
- Publication number 20210221771
- Publication date Jul 22, 2021
- Amgen Inc.
- Henry Morrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF OMECAMTIV MECARBIL
- Publication number 20200308143
- Publication date Oct 1, 2020
- Amgen Inc.
- Sebastien Caille
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20200281912
- Publication date Sep 10, 2020
- AMGEN IINC.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20180092898
- Publication date Apr 5, 2018
- Amgen Inc.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20160289190
- Publication date Oct 6, 2016
- Amgen Inc.
- Matthew BIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20160289178
- Publication date Oct 6, 2016
- Amgen Inc.
- Sebastien CAILLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20160287570
- Publication date Oct 6, 2016
- Amgen Inc.
- Matthew BIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20160289243
- Publication date Oct 6, 2016
- Amgen Inc.
- Matthew BIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20160264526
- Publication date Sep 15, 2016
- Amgen Inc.
- Matthew BIO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
- Publication number 20140364455
- Publication date Dec 11, 2014
- Matthew BIO
- C07 - ORGANIC CHEMISTRY

Sebastien CAILLE

Person

Patents Grantslast 30 patents

Synthesis of omecamtiv mecarbil

Salts and crystal forms of omecamtiv mecarbil

Synthesis of omecamtiv mecarbil

Processes for preparing a MDM2 inhibitor

Synthesis of omecamtiv mecarbil

Salts and crystal forms of omecamtiv mecarbil

Synthesis of omecamtiv mecarbil

Processes of making and crystalline forms of a MDM2 inhibitor

Processes of making and crystalline forms of a MDM2 inhibitor

Calcium propane-2-sulfinate dihydrate

Processes of making and crystalline forms of a MDM2 inhibitor

Processes of making and crystalline forms of a MDM2 inhibitor

Patents Applicationslast 30 patents

SYNTHESIS OF A KIF18A INHIBITOR

SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL

Processes for Preparing a MDM2 Inhibitor

SYNTHESIS OF OMECAMTIV MECARBIL

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND

SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL

SYNTHESIS OF OMECAMTIV MECARBIL

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

SYNTHESIS OF OMECAMTIV MECARBIL

Processes for Preparing a MDM2 Inhibitor

SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL

SYNTHESIS OF OMECAMTIV MECARBIL

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR